medigraphic.com
Colegio de Medicina Interna de México.

2015, Number 6

<< Back Next >>

Med Int Mex 2015; 31 (6)

Idiopathic intracranial hypertension

Buelna-Cano C, Moreno-Ulloa J

Language: Spanish
References: 10
Page: 761-767
PDF size: 513.76 Kb.


ABSTRACT

Idiopathic intracranial hypertension is a syndrome characterized by increased intracranial pressure without ventriculomegaly or intracranial tumor with normal cerebrospinal fluid, causing signs and symptoms of intracranial hypertension. The risk factors include: obesity, use of oral contraceptives, pregnancy and obstructive sleep apnea. The diagnostic criteria are symptoms and signs that reflect intracranial hypertension or papilledema, intracranial pressure greater than 250 mm of H2O, composition of normal CSF and imaging study without evidence of ventricular dilatation, tumor, vascular damage or structural injury in MRI or contrasted CT of brain. The therapeutic management should be based on reducing the intracranial pressure, in order to relieve headache and preserve vision.


REFERENCES

  1. McGeeney B, Friedman D. Pseudotumor cerebri pathophysiology. Headache 2014;54:445-458.

  2. Wakerley B, Tan M, Ting E. Idiopathic intracranial hypertension. Cephalalgia 2015;35:248-261.

  3. Ducros A, Biousse V. Headache arising from idiopathic changes in CSF pressure. Lancet Neurol 2015;14:655-668.

  4. Friedman DI. The Pseudotumor cerebri syndrome. Neurol Clin 2014;32:363-396.

  5. Oresković D, Klarica M. The formation of cerebrospinal fluid: nearly a hundred years of interpretations and misinterpretations. Brain Res Rev 2010;64:241-262.

  6. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension, neurology 2002;59:1492-1495.

  7. Kosmorsky GS. Idiopathic intracranial hypertension: pseudotumor cerebri. Headache 2014;54:389-393.

  8. Kupersmith M, Gamell L, Turbin R. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 1998;50:1094-1098.

  9. Horton J. Acetazolamide for pseudotumor cerebro: evidence from the NORDIC trial. JAMA 2014;311:1618-1619.

  10. Galgano M, Deshaies EM. An update on the management of pseudotumor cerebri. Clin Neurol Neurosurg 2013;115:252-259.




2020     |     www.medigraphic.com